Genomic sequencing can reveal microbiome richness and diversity – which and how many microbes are present – in a given microbiome, but cannot effectively measure what small molecule end products are bring produced, how they behave, or how they directly impact health. Global metabolomics provides the needed next level of understanding by revealing functional activity of microbes in a living system.
Metabolomics has the unique ability to detect microbial-derived biochemicals entering the bloodstream, crossing the gut-brain axis and interacting with other functional organs to inform on the microbiome’s role in influencing overall health.
Metabolon’s global metabolomics platform provides a full view on host metabolism, xenobiotics, dietary metabolites and novel metabolites produced by the microbiome to guide which microbes and pathways to focus on for the desired therapeutic effect.
Select from a series of targeted assay panels to measure effects on microbiome-related analytes with quantifiable and comparable data. Add to Metabolon’s global untargeted approach for the most comprehensive, precise and systematic view of microbiome related activity and actionable insights.